Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illumina, Inc. (ILMN) vs Prospect Capital Corporation (PSEC) Price & Performance

Illumina, Inc.Trade
Prospect Capital CorporationTrade

Price performance (Past 24H)

Key statistics

Illumina, Inc. vs Prospect Capital Corporation — how do they compare? Illumina, Inc. trades at $192.8 (market cap $27.94B), while Prospect Capital Corporation trades at $2.17 (market cap $1.12B). The key difference: Illumina, Inc. is far larger — about 24.9× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 22.42% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.

ILMNPSEC
Market Cap
$27.94B$1.12B
Sector
HealthFinancials
52-Week High
$194.33$3.47
52-Week Low
$91.00$2.15
Enterprise Value
$29.33B
Dividend Yield
22.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN

About Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Read more on PSEC